Heartbran® is a novel patented food ingredient in the US, Europe, Singapore, Israel, Australia, Mexico, Japan & Canada.
The ingredient is a combination of whole rice bran (including the plant sterol, gamma oryzanol & fiber), vitamins and
omega 3 rich fish oil in a stabilized powder system. The combination of the 3 heart healthy factors into one system is unique
in the food ingredient. Specifications of the 3 components vary according to the application. An additional benefit
is the ability to use the ingredients in gluten-free & natural food applications, as well as dietary supplements. The
ingredient is suitable for addition to yogurt-type smoothies, cereal, bars, snacks, bakery and ready to eat meals. Microencapsulation
is employed for taste masking of the vitamins and the fish oil. Creativity is used to bring the ingredient to R&D departments
in a food system that will be consumer acceptable. Much of the flavor work will be done before presentation to companies
so that the taste has already been proven, lessening the burden on product development teams.
placebo controlled clinical study has been completed by the Pennington Biomedical Center in Baton Rouge, Louisiana that explored
the scientific claims of the product. The findings were presented at the Experimental Biology meeting on April 4, 2005 in
San Diego. See the science page for an abstract of the poster presentation.
In August of 2006, a focus group study of celiac sprue patients in Baton Rouge, Louisiana were presented with
several Light Heart® brand retail ready items and stated that they would look for the brand in different sections of a
store such as Whole Foods Market. In January of 2007, Light Heart dietary supplement, chocolate bars for heart &
digestive health were test marketed in Whole Foods Markets in Southern California with good success in the gluten free and
bar sections of the stores. By year end 2008, the bars were ready for national launch with a shelf life of 1 year.
Omega 3 Fatty Acids
England Journal of Medicine, Vol. 334, Nov. 24, June 13, 1996, pp. 1557-60.
Arteriosclerosis, Thrombosis, and Vascular
The Lancet, Vol 354, Aug. 7, 1999, pp. 447-55.
Stark, KD; Park, EJ; Mains, VA; Holub, BJ;
Am. Journal of Clinical Nutrition 72(2):389-94, 2000.
Nestel, PJ; Am. Journal of Clinical Nutrition 71(suppl. 1):2285-315,
Durrington, PN; Bhatnagar, D; Mackness, MI; Morgan, J; Julier, K; Khan, MA; France, M; Heart 85:544-548, 2001.
Journal of Clinical Nutrition 76:326-30, 2002.
JAMA 288, No. 24:3130-3136, December 25, 2002.
The Lancet, Vol. 361,
No. 9356, p. 477-85, Feb. 8, 2003.
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003, 23:e20.
Al & Gallo, NB. The Journal of Nutrition, 128 (5): 865-9, May 1998.
Jariwalla, RJ. Drugs Exp. Clinical Research, XXVII(1),
Qureshi, AA; Sami, SA; Salsen, WA; Khan, FA. Atherosclerosis, 161(1): 199-207, March 2002.
and Technology, 3rd ed. Elaine T. Champagne, editor, American Association of Cereal Chemists, 2004, pp. 91-190.
JW. Am. Journal of Clinical Nutrition 78(3), 441-447, Sept. 2003.
C Reactive Protein
Circulation, July 15, 2003;
Vol 108, pp. 150-154.
British Medical Journal, Nov. 22, 2002; Vol 325, pp. 1202-6.